Day 1 at MedTech World North America 2026 focused on market access, investment trends, and collaboration

The first full day of MedTech World North America 2026 brought together founders, investors, healthcare leaders, clinicians, and strategic partners for a packed agenda centered on the realities of scaling MedTech companies in today’s market. From discussions around hospital procurement and US market entry to surgical robotics, women’s health, cardio care, and commercialization strategy, the conversations throughout the day reflected both the opportunities and pressures of the sector in 2026.

The morning officially opened with welcome remarks from Dr. Dylan Attard, CEO and Co-founder of MedTech World, who spoke about the importance of creating spaces where innovation, investment, and healthcare leadership can connect in practical ways. This was followed by an opening keynote from H.E. Dr. Godfrey Carmel Xuereb, Ambassador of the Republic of Malta to the United States, who highlighted the growing role of international collaboration in healthcare innovation and the value of strengthening cross-border relationships within the MedTech ecosystem.

Conversations centered on scaling and commercialization

The day’s opening panel explored what it takes for startups to successfully engage with enterprise health systems in 2026. The discussion examined how procurement decisions are evolving, what healthcare systems expect from emerging companies, and how innovators can better position themselves for pilots, partnerships, and long-term adoption. Speakers also addressed the increasing importance of demonstrating operational value alongside clinical outcomes.

This theme of market readiness continued into a session focused on entering and scaling within the US healthcare market. Conversations centered on aligning regulatory planning, reimbursement strategy, and commercialization efforts early in a company’s journey to avoid delays and improve adoption. Panelists discussed how startups can approach their first customers more strategically while navigating increasingly complex healthcare pathways.

Investment and funding remained central themes throughout the program. One panel examined how hospital venture funds are becoming more involved in innovation ecosystems, not only as financial backers but also as strategic collaborators that provide clinical validation, pilot opportunities, and access to healthcare networks. The discussion highlighted the growing overlap between investment activity and real-world implementation within hospitals and health systems.

Later in the afternoon, another widely attended panel explored where capital is moving within MedTech in 2026. Speakers shared perspectives on the sectors attracting investor attention, how funding priorities are shifting, and what founders need to demonstrate in today’s more selective investment environment. Rather than focusing solely on fundraising, the conversation emphasized readiness, execution, and long-term sustainability.

Additional sessions throughout the afternoon focused on practical commercialization strategies for startups preparing for growth and revenue generation. Discussions examined common mistakes companies make before launch, the importance of operational readiness, and how founders can better align product development with market realities.

Another panel explored the growing role of surgical robotics and smart operating room technologies in mid-sized hospitals. Conversations focused on making advanced technologies more accessible through practical deployment models, financing structures, and scalable solutions rather than positioning robotics as tools limited to major academic institutions.

Women’s health was also a major topic during the day, with discussions highlighting areas receiving increased attention beyond fertility and pregnancy. Speakers examined opportunities and challenges across menopause care, pelvic health, oncology, and other underserved segments that continue to attract both innovation and investment interest.

The final panel of the day focused on the cardio care continuum and how care delivery is increasingly extending beyond hospital walls. Conversations explored remote monitoring, integrated care pathways, and reimbursement-ready models designed to support ongoing patient management from hospital to home.

A busy exhibition floor and startup village

Beyond the conference sessions, the exhibition floor remained active throughout the day, with attendees moving between company booths, partner activations, and startup kiosks across the venue. The Startup Village in particular captured much of the day’s energy, bringing together early-stage innovators showcasing technologies across AI, digital health, robotics, diagnostics, compliance, and patient care.

Company showcases throughout the day also gave founders an opportunity to present their solutions directly to investors, partners, and healthcare stakeholders attending the conference. The exhibition space became a natural extension of the stage discussions, with conversations continuing well beyond individual sessions.

Another focal point of the venue was the dedicated 1:1 networking area, where scheduled meetings took place continuously throughout the day. Founders, investors, healthcare executives, and strategic partners used the space for introductions, partnership discussions, investment meetings, and follow-up conversations sparked during panels and networking sessions.

Alongside the main stage programming, attendees also gathered for the invite-only luncheon discussion titled FDA, Payers & Hackers: The Three Forces That Make or Break a Launch. Powered by Blue Goat Cyber, the session examined how cybersecurity, reimbursement, and regulatory considerations are becoming deeply interconnected for MedTech companies preparing to commercialize new technologies.

Networking continued into the evening

As the conference program concluded, closing remarks reflected on the day’s themes of collaboration, commercialization, and strategic growth while setting the stage for Day 2.

The evening continued with networking activities, including the Prolucid Happy Hour and the Evening Networking VIP Reception powered by Blue Goat Cyber. Held at IL Bellagio Italian Restaurant, the reception brought together investors, CEOs, founders, and industry leaders in a more intimate setting designed to encourage meaningful conversations and future partnerships.

With Day 1 now complete, attention turns to the next phase of MedTech World North America 2026, where discussions around innovation, investment, partnerships, and healthcare transformation are set to continue. Among the most anticipated moments of Day 2 is the MedTech World Startup Pitch Competition, where emerging companies will take the stage to present their technologies and business models before a panel of judges, investors, and industry stakeholders. The competition is expected to bring additional energy to the conference as startups compete for visibility, strategic connections, and recognition within the global MedTech community.

To stay updated with the latest highlights from the event and watch sessions live, follow MedTech World on YouTube.